 |
 |
 |
|
|
|||
|
|
||||
|
||||
INFERTILITY: Wall Street Journal Examines New Measure In Fertility TestingFrom: Hope Waltman (anonymous@obgyn.net)Sun, 27 Apr 2008 07:06:07 -0500 (CDT)
"The Wall Street Journal on Tuesday examined a hormone test "gaining wider use" in the U.S. that might provide a "more accurate snapshot of a woman's egg count" compared with commonly used tests in the U.S. According to the Journal, the test measures a chemical in the body called anti-mullerian hormone, or AMH, from a blood sample. The test has been available in Europe but is still awaiting FDA approval. According to the Journal, a study published in the journal Fertility and Sterility last year reviewed data from a series of AMH studies and concluded that it is the earliest marker of ovarian reserve and has the least variability during and between a woman's menstrual cycles -- compared with an older, commonly used egg-supply marker called follicle-stimulating hormone, or FSH." http://www.medicalnewstoday.com/articles/105148.php Regards, Hope Waltman, Fibroid Forum and WH Forum Moderator http://www.hopeforfibroids.org http://www.doctorsinfoweb.com/doctors.htm UTERINE FIBROIDS INFO: http://www.obgyn.net/fibroid-resource-center/
|
|
Return to ![[ Women's Health Forum ]](http://www.obgyn.net/images_women/wh-forum.gif)
Report TECHNICAL Problems ONLY to: webmaster@obgyn.net
Last Updated: Wed Jul 2 06:11:47 2008